1.   A Holzmann organised and supervised the screening of serum samples for hepatitis.

2.   A nasopharyngeal swab or paired serum samples, or both, were collected from healthy subjects.

3.   The drug in the serum sample and the enzyme.

4.   Measurements of bismuth in serum samples during the trial enabled us to monitor whether significant accumulation occurred.

5.   In vitro effects of cytokines and therapeutic drugs on antibody dependent cellular cytotoxicity mediated by anticolon antibody were investigated in serum samples from patients with ulcerative colitis.

6.   This ADCC activity was inhibited by protein A treatment of the serum samples.

7.   Circulating anticolon antibodies have been found in serum samples from patients with ulcerative colitis.